comparison the effect of Erector Spinae Block VS Pectoral 1 Block on post operative pain , nausea and vomiting in breast mass surgeries ; a double blind randomized study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181126041760N1

Enrollment

Registered

2019-07-23

Start date

2019-05-08

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia in chest wall operations. benign mammary dysplasia skin of breast

Interventions

Intervention 1: Intervention group: pecs1 block/ after consent for regional block , qualified person put in table of random numbers.before general anesthesia in aseptic field on sonography guide we di

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: women age 18-50 ASA class 1-2 insensitivity to LA No psychotic disorder No addiction no hemostasis disorder no local skin infection no use analgesic and NSAID drugs

Exclusion criteria

Exclusion criteria: operation time more than 4 hours excessive blood loss changing procidure type

Design outcomes

Primary

Measure	Time frame
PAIN. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: visual analogue scale.;Nausea. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: questionnaire.;Vomiting. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: questionnaire.;Blood Pressure. Timepoint: after injection/15minutes after/30minutes after/45minutes after/60minutes after/75minutes after/90minutes after/2hours after/3hours after/4hours after/6hours after. Method of measurement: BP monitoring (mmhg).;Herat rate. Timepoint: after injection/15minutes after/30minutes after/45minutes after/60minutes after/75minutes after/90minutes after/2hours after/3hours after/4hours after/6hours after. Method of measurement: HR monitoring.;Need for narcotic. Timepoint: Recovery/60 minutes after recovery/2 hours after recovery/4 hours after recovery/6 hours after recovery. Method of measurement: patient file (macrogram).	—

Measure

Time frame

PAIN. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: visual analogue scale.;Nausea. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: questionnaire.;Vomiting. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: questionnaire.;Blood Pressure. Timepoint: after injection/15minutes after/30minutes after/45minutes after/60minutes after/75minutes after/90minutes after/2hours after/3hours after/4hours after/6hours after. Method of measurement: BP monitoring (mmhg).;Herat rate. Timepoint: after injection/15minutes after/30minutes after/45minutes after/60minutes after/75minutes after/90minutes after/2hours after/3hours after/4hours after/6hours after. Method of measurement: HR monitoring.;Need for narcotic. Timepoint: Recovery/60 minutes after recovery/2 hours after recovery/4 hours after recovery/6 hours after recovery. Method of measurement: patient file (macrogram).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHouman Teymourian

Shahid Beheshti University of Medical Sciences

houman72625@yahoo.com+98 21 2274 1174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026